{"id":2016,"date":"2023-05-17T14:53:13","date_gmt":"2023-05-17T19:53:13","guid":{"rendered":"https:\/\/myeloma.ca\/myeloma-related-disorders-and-diseases\/"},"modified":"2026-06-02T14:02:08","modified_gmt":"2026-06-02T19:02:08","slug":"troubles-et-maladies-associes-a-un-myelome","status":"publish","type":"page","link":"https:\/\/myeloma.ca\/fr\/diagnostic-recent\/comprendre-son-diagnostic\/troubles-et-maladies-associes-a-un-myelome\/","title":{"rendered":"Troubles et maladies associ\u00e9s \u00e0 un my\u00e9lome"},"content":{"rendered":"<div class=\"page-intro-block   block_3dfa5fb583f4ce503e0ec66b86d7741d\">\n    <div class=\"container\">\n        <div class=\"left-content\">\n            <div class=\"content\">\n                <h1><strong class='second-font-family is-italic is-italic-fw'>Troubles et maladies<\/strong> associ\u00e9s \u00e0 un my\u00e9lome <\/h1>\n            <\/div>\n            <div class=\"bottom-content\">\n                <div class=\"actions-btns-wrapper\">\n                    <a class=\"print-btn\" href=\"#\">\n                        <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"13.545\" height=\"14.195\" viewBox=\"0 0 13.545 14.195\"><path d=\"M13.786,9.785v-2.6H7.759v2.6H6.743V6H14.8V9.785Zm-8.77,1.183h0Zm10.142,1.873a.457.457,0,0,0,.356-.177.639.639,0,0,0,0-.828.445.445,0,0,0-.711,0,.639.639,0,0,0,0,.828A.457.457,0,0,0,15.158,12.841Zm-1.371,6.171V15.227H7.759v3.785ZM14.8,20.2H6.743v-3.47H4v-4.85a2.2,2.2,0,0,1,.516-1.489,1.619,1.619,0,0,1,1.278-.6H15.75a1.619,1.619,0,0,1,1.278.6,2.2,2.2,0,0,1,.516,1.489v4.85H14.8Zm1.727-4.653V11.875a.963.963,0,0,0-.22-.651.7.7,0,0,0-.559-.256H5.795a.7.7,0,0,0-.559.256.963.963,0,0,0-.22.651v3.667H6.743v-1.5H14.8v1.5Z\" transform=\"translate(-4 -6)\" fill=\"#3e3a3b\"\/><\/svg>\n                        <span>Imprimer<\/span>\n                    <\/a>\n                    <a class=\"share-btn\" href=\"mailto:?subject=I wanted you to see this!&amp;body=https:\/\/myeloma.ca\/fr\/diagnostic-recent\/comprendre-son-diagnostic\/troubles-et-maladies-associes-a-un-myelome\/\">\n                        <svg height=\"14.195\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 512 512\"><path d=\"M64 96c-17.7 0-32 14.3-32 32v39.9L227.6 311.3c16.9 12.4 39.9 12.4 56.8 0L480 167.9V128c0-17.7-14.3-32-32-32H64zM32 207.6V384c0 17.7 14.3 32 32 32H448c17.7 0 32-14.3 32-32V207.6L303.3 337.1c-28.2 20.6-66.5 20.6-94.6 0L32 207.6zM0 128C0 92.7 28.7 64 64 64H448c35.3 0 64 28.7 64 64V384c0 35.3-28.7 64-64 64H64c-35.3 0-64-28.7-64-64V128z\"\/><\/svg>\n                        <span>Partager<\/span>\n                    <\/a>\n                <\/div>\n                <div class=\"lb-breadcrumb\">\n                    <div class=\"lb-breadcrumbs\"><span><a href=\"https:\/\/myeloma.ca\/fr\/\">Accueil<\/a><\/span><span class=\"lb-breadcrumb-separator\"> | <\/span><\/div>                <\/div>\n            <\/div>\n\n        <\/div>\n    <\/div>\n    <div class=\"page-intro-image-wrapper\">\n\t\t<img loading=\"lazy\" decoding=\"async\" width=\"725\" height=\"725\" src=\"https:\/\/myeloma.ca\/wp-content\/uploads\/2023\/10\/myeloma_related_disorders_hero.jpg\" class=\"attachment-full size-full\" alt=\"Une femme enlace un homme par derri\u00e8re l&#039;air paisible\" \/>    <\/div>\n        <div class=\"left-content mobile\">\n            <div class=\"bottom-content\">\n                <div class=\"actions-btns-wrapper\">\n                    <a class=\"print-btn\" href=\"#\">\n                        <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"13.545\" height=\"14.195\" viewBox=\"0 0 13.545 14.195\"><path d=\"M13.786,9.785v-2.6H7.759v2.6H6.743V6H14.8V9.785Zm-8.77,1.183h0Zm10.142,1.873a.457.457,0,0,0,.356-.177.639.639,0,0,0,0-.828.445.445,0,0,0-.711,0,.639.639,0,0,0,0,.828A.457.457,0,0,0,15.158,12.841Zm-1.371,6.171V15.227H7.759v3.785ZM14.8,20.2H6.743v-3.47H4v-4.85a2.2,2.2,0,0,1,.516-1.489,1.619,1.619,0,0,1,1.278-.6H15.75a1.619,1.619,0,0,1,1.278.6,2.2,2.2,0,0,1,.516,1.489v4.85H14.8Zm1.727-4.653V11.875a.963.963,0,0,0-.22-.651.7.7,0,0,0-.559-.256H5.795a.7.7,0,0,0-.559.256.963.963,0,0,0-.22.651v3.667H6.743v-1.5H14.8v1.5Z\" transform=\"translate(-4 -6)\" fill=\"#3e3a3b\"\/><\/svg>\n                        <span>Imprimer<\/span>\n                    <\/a>\n                    <a class=\"share-btn\" href=\"mailto:?subject=I wanted you to see this!&amp;body=https:\/\/myeloma.ca\/fr\/diagnostic-recent\/comprendre-son-diagnostic\/troubles-et-maladies-associes-a-un-myelome\/\">\n                        <svg height=\"14.195\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 512 512\"><path d=\"M64 96c-17.7 0-32 14.3-32 32v39.9L227.6 311.3c16.9 12.4 39.9 12.4 56.8 0L480 167.9V128c0-17.7-14.3-32-32-32H64zM32 207.6V384c0 17.7 14.3 32 32 32H448c17.7 0 32-14.3 32-32V207.6L303.3 337.1c-28.2 20.6-66.5 20.6-94.6 0L32 207.6zM0 128C0 92.7 28.7 64 64 64H448c35.3 0 64 28.7 64 64V384c0 35.3-28.7 64-64 64H64c-35.3 0-64-28.7-64-64V128z\"\/><\/svg>\n                        <span>Partager<\/span>\n                    <\/a>\n                <\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n\n<div class=\"master-tabs-block   block_22cadef621dd15f3faeb7474365b813e  \">\n    <div class=\"container\">\n        <div class=\"tab-selector-wrapper\">\n        <\/div>\n    <\/div>\n    <div class=\"acf-innerblocks-container\">\n<div data-tab-name=\"Troubles et maladies associ\u00e9s \u00e0 un my\u00e9lome \"\n     id=\"troubles-et-maladies-associes-a-un-myelome\"\n     class=\"master-tab-block   block_2dcf44264236949ef113eadd87018d3f\">\n    <div class=\"lm-tab-content\">\n        <div class=\"acf-innerblocks-container\">\n\t<div data-anchor-name=\"GMSI et my\u00e9lome indolent\"\n         id=\"gmsi-et-myelome-indolent\"\n         class=\"master-anchor-block\"\n    ><\/div>\n<div class=\" content-1-block m-pt2 m-pb3   block_8d9dfcbefdbbb8ef7e34ecce0f59db06  \" style=\"padding-top: var(--wp--preset--spacing--70);padding-bottom: var(--wp--preset--spacing--70);text-align: center;\">\n    <div class=\"container\">\n\t\t        <div class=\"content\">\n\t\t\t<h2>GMSI et my\u00e9lome indolent<\/h2>\n<p>Des conditions telles que la gammopathie monoclonale de signification ind\u00e9termin\u00e9e (GMSI) et un my\u00e9lome indolent ou latent sont typiquement asymptomatiques, mais peuvent \u00eatre des pr\u00e9curseurs d\u2019un my\u00e9lome actif (ou symptomatique). Des ant\u00e9c\u00e9dents de <a href=\"https:\/\/myeloma.ca\/fr\/diagnostic-recent\/comprendre-son-diagnostic\/quelles-sont-les-causes-dun-myelome\/#plasmacytome-solitaire\"><u>plasmocytomes solitaires<\/u><\/a> peuvent \u00e9galement \u00eatre un signe pr\u00e9curseur de la maladie.<\/p>\n<div class=\"lb-button-wrapper\"><a class=\"btn btn-filled \" target=\"_self\" href=\"https:\/\/myeloma.ca\/fr\/diagnostic-recent\/quelles-sont-les-causes-dun-myelome\/#precurseurs-dun-myelome\"><span>En savoir plus sur la GMSI et un my\u00e9lome indolent <\/span><\/a><\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n\t<div data-anchor-name=\"Maladie osseuse associ\u00e9e \u00e0 un my\u00e9lome\"\n         id=\"maladie-osseuse-associee-a-un-myelome\"\n         class=\"master-anchor-block\"\n    ><\/div>\n<div class=\" content-2-block m-pt2 m-pb3   block_f1e4026c45f1d46be33b4461e207d6ca      has-image   \" style=\"background-color: var(--lb--light-grey);color: #3E3A3B;\">\n    <div class=\"container\">\n        <div class=\"grid-content-2\">\n                            <div class=\"img-wrapper \">\n                    <img loading=\"lazy\" decoding=\"async\" width=\"470\" height=\"550\" src=\"https:\/\/myeloma.ca\/wp-content\/uploads\/2023\/10\/myeloma_bone_disease.jpg\" class=\"content-2-img\" alt=\"Un homme asiatique \u00e2g\u00e9e regarde au loin en souriant\" srcset=\"https:\/\/myeloma.ca\/wp-content\/uploads\/2023\/10\/myeloma_bone_disease.jpg 470w, https:\/\/myeloma.ca\/wp-content\/uploads\/2023\/10\/myeloma_bone_disease-256x300.jpg 256w\" sizes=\"auto, (max-width: 470px) 100vw, 470px\" \/>                <\/div>\n                        <div class=\"content\">\n                <div>\n\t\t\t\t\t\t\t\t\t\t<h3><strong class='second-font-family is-italic is-italic-fw'>Maladie osseuse<\/strong> associ\u00e9e \u00e0 un my\u00e9lome<\/h3>\n<p>La caract\u00e9ristique la plus courante et la plus d\u00e9bilitante d\u2019un my\u00e9lome est la mani\u00e8re dont il affecte les os de l\u2019ensemble du corps.<\/p>\n<p>Plus de 70\u00a0% des personnes atteintes ressentent des douleurs osseuses et pr\u00e9sentent des signes de maladie osseuse associ\u00e9e \u00e0 un my\u00e9lome au moment o\u00f9 ils re\u00e7oivent leur diagnostic. Presque toutes les personnes atteintes pr\u00e9senteront, \u00e0 un moment de leur parcours avec un my\u00e9lome, une maladie osseuse associ\u00e9e \u00e0 un my\u00e9lome.<\/p>\n<p><strong><br \/>\nMais&#8230; un my\u00e9lome n\u2019est-il pas un cancer du sang?<\/strong><\/p>\n<p>Oui. M\u00eame s\u2019il affecte les os, un my\u00e9lome est consid\u00e9r\u00e9 comme un cancer du sang, car il est caus\u00e9 par des plasmocytes anormaux (cellules my\u00e9lomateuses) produits dans la moelle osseuse.<\/p>\n                <\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n\t<div data-anchor-name=\"Comment les maladies osseuses se manifestent-elles?\"\n         id=\"comment-les-maladies-osseuses-se-manifestent-elles\"\n         class=\"master-anchor-block\"\n    ><\/div>\n<div class=\"squares-row-block m-pt2 m-pb3   block_7a1cc3564c54b7fa5e71447af05bcd96\" style=\"padding-bottom: var(--wp--preset--spacing--70);background-color: var(--lb--light-grey);\">\n    <div class=\"container\">\n\t\t            <h2 class=\"squares-row-title text-center\">Comment les maladies osseuses se manifestent-elles chez les personnes atteintes d\u2019un my\u00e9lome?<\/h2>\n\t\t\n        <div class=\"grid-squares  \">\n\t\t\t                <div class=\"single-square\">\n\t\t\t\t\t                        <div class=\"square-icon\"><img loading=\"lazy\" decoding=\"async\" width=\"43\" height=\"43\" src=\"https:\/\/myeloma.ca\/wp-content\/uploads\/2023\/02\/Groupe-796.svg\" class=\"attachment-full size-full\" alt=\"bone icon\" \/><\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t                        <div class=\"content\"><p>Tout au long de la vie, les os du corps humain sont constamment remodel\u00e9s par 2\u00a0types de cellules compl\u00e9mentaires appel\u00e9es ost\u00e9oblastes et ost\u00e9oclastes.<\/p>\n<\/div>\n\t\t\t\t\t                <\/div>\n\t\t\t                <div class=\"single-square\">\n\t\t\t\t\t                        <div class=\"square-icon\"><img loading=\"lazy\" decoding=\"async\" width=\"34\" height=\"34\" src=\"https:\/\/myeloma.ca\/wp-content\/uploads\/2023\/02\/Groupe-797.svg\" class=\"attachment-full size-full\" alt=\"icone\" \/><\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t                        <div class=\"content\"><p>Les ost\u00e9oclastes assurent la d\u00e9composition des tissus osseux us\u00e9s, et les ost\u00e9oblastes en forment de nouveaux pour les remplacer. Normalement, ces deux types de cellules travaillent au m\u00eame rythme, de sorte que le taux de formation osseuse est \u00e9gal au taux de d\u00e9t\u00e9rioration osseuse. Ainsi, la masse osseuse demeure toujours relativement la m\u00eame.<\/p>\n<\/div>\n\t\t\t\t\t                <\/div>\n\t\t\t                <div class=\"single-square\">\n\t\t\t\t\t                        <div class=\"square-icon\"><img loading=\"lazy\" decoding=\"async\" width=\"43\" height=\"34\" src=\"https:\/\/myeloma.ca\/wp-content\/uploads\/2023\/02\/Groupe-798.svg\" class=\"attachment-full size-full\" alt=\"icone\" \/><\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t                        <div class=\"content\"><p>Dans le cas d\u2019un my\u00e9lome, des plasmocytes anormaux (cellules my\u00e9lomateuses) envoient des signaux qui emp\u00eachent les ost\u00e9oblastes de construire de nouveaux os et acc\u00e9l\u00e8rent l\u2019activit\u00e9 de d\u00e9gradation des ost\u00e9oclastes. En d\u2019autres termes, l\u2019os se d\u00e9grade plus vite qu\u2019il ne peut \u00eatre construit ou renouvel\u00e9.<\/p>\n<\/div>\n\t\t\t\t\t                <\/div>\n\t\t\t        <\/div>\n\n        \n\t\t\n    <\/div>\n<\/div>\n\n<div class=\"cta-1-block p-pb5   block_20fcd05b8ec39a8bd95fe5013f8c20e9\" style=\"padding-top: var(--wp--preset--spacing--70);padding-bottom: 8rem;background-color: var(--lb--light-grey);\">\n    <div class=\"container\">\n        <div class=\"cta-1-wrapper\">\n            <div class=\"img-wrapper\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"487\" height=\"633\" src=\"https:\/\/myeloma.ca\/wp-content\/uploads\/Infoguide-FR-Bone.png\" class=\"attachment-large size-large\" alt=\"\" srcset=\"https:\/\/myeloma.ca\/wp-content\/uploads\/Infoguide-FR-Bone.png 487w, https:\/\/myeloma.ca\/wp-content\/uploads\/Infoguide-FR-Bone-231x300.png 231w\" sizes=\"auto, (max-width: 487px) 100vw, 487px\" \/>            <\/div>\n            <div class=\"content-wrapper\">\n                <h3>Pour en savoir plus, consultez notre <i>InfoGuide La maladie osseuse associ\u00e9e au my\u00e9lome multiple<\/i>.<\/h3>\n                            <\/div>\n                            <div class=\"button-wrapper\">\n                    <a class=\"btn btn-empty\" target=\"_blank\" href=\"https:\/\/myeloma.ca\/wp-content\/uploads\/Infoguide-FR-Bone.pdf\">T\u00e9l\u00e9charger un exemplaire<\/a>\n                <\/div>\n                    <\/div>\n    <\/div>\n<\/div>\n\n\t<div data-anchor-name=\"Autres troubles associ\u00e9s \u00e0 un my\u00e9lome\"\n         id=\"autres-troubles-associes-a-un-myelome\"\n         class=\"master-anchor-block\"\n    ><\/div>\n\n<div class=\"lb-accordion accordion-block   block_8945537ffeae86de90bbc490b7756791 \" style=\"padding-top: var(--wp--preset--spacing--60);padding-bottom: var(--wp--preset--spacing--70);\">\n    <div class=\"container\">\n        <div class=\"pre-accordion-content\">\n\t\t\t                <h2>Autres <strong class='second-font-family is-italic is-italic-fw'>troubles<\/strong> associ\u00e9s \u00e0 un my\u00e9lome <\/h2>\n\t\t\t\t\t\t        <\/div>\n\t\t            <div class=\"accordion-wrapper\">\n\t\t\t\t                    <div class=\"lb-accordion-single \">\n                        <button class=\"lb-accordion-button\"\n                                type=\"button\">\n                            <span>My\u00e9lome et maladie r\u00e9nale<\/span>\n                        <\/button>\n                        <div class=\"lb-accordion-content\" style=\"\">\n                            <div class=\"lb-accordion-inner-wrapper\">\n\t\t\t\t\t\t\t\t<p>Les personnes atteintes d\u2019un my\u00e9lome pr\u00e9sentent un risque accru de d\u00e9velopper une maladie r\u00e9nale.<\/p>\n<ul>\n<li>Au moins 20 % des personnes atteintes d\u2019un my\u00e9lome pr\u00e9sentent un certain degr\u00e9 d\u2019insuffisance r\u00e9nale au moment du diagnostic.<\/li>\n<li>Jusqu\u2019\u00e0 50 % des personnes d\u00e9veloppent une maladie r\u00e9nale \u00e0 un certain moment au cours de l\u2019\u00e9volution de leur my\u00e9lome.Il est important de comprendre pourquoi un my\u00e9lome augmente le risque de maladie r\u00e9nale et ce que vous pouvez faire pour r\u00e9duire ce risque.<\/li>\n<\/ul>\n<p>La maladie r\u00e9nale caus\u00e9e par un my\u00e9lome peut se produire pour diverses raisons :<\/p>\n<ul>\n<li>la prot\u00e9ine anormale produite par les cellules my\u00e9lomateuses bloque les tubules du rein;<\/li>\n<li>d\u2019autres complications d\u2019un my\u00e9lome, comme la d\u00e9shydratation ou un taux de calcium \u00e9lev\u00e9 (hypercalc\u00e9mie);<\/li>\n<li>certains des m\u00e9dicaments utilis\u00e9s dans le traitement d\u2019un my\u00e9lome peuvent causer ou contribuer \u00e0 la maladie r\u00e9nale associ\u00e9e \u00e0 un my\u00e9lome.<\/li>\n<\/ul>\n<div class=\"lb-button-wrapper\"><a class=\"btn-with-icon \" target=\"_blank\" href=\"https:\/\/myeloma.ca\/wp-content\/uploads\/Infoguide-FR-Kidney.pdf\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" width=\"20\" height=\"20\" viewBox=\"0 0 20 20\"> <g transform=\"translate(-406 -2843)\"> <circle cx=\"10\" cy=\"10\" r=\"10\" transform=\"translate(406 2843)\" fill=\"#1c596c\"\/> <g transform=\"translate(412.135 2845)\"> <g transform=\"translate(10.732 7.866) rotate(135)\"> <path d=\"M0,4.968V0H4.968\" transform=\"translate(3.389 2.774)\" fill=\"none\" stroke=\"#fff\" stroke-linecap=\"round\" stroke-miterlimit=\"10\" stroke-width=\"1\"\/> <\/g> <\/g> <\/g> <\/svg><span>Pour en savoir plus, consultez notre InfoGuide Le my\u00e9lome et les reins.<\/span><\/a><\/div>\n                            <\/div>\n                        <\/div>\n                    <\/div>\n\t\t\t\t                    <div class=\"lb-accordion-single \">\n                        <button class=\"lb-accordion-button\"\n                                type=\"button\">\n                            <span>Amylose AL \u00e0 cha\u00eenes l\u00e9g\u00e8res<\/span>\n                        <\/button>\n                        <div class=\"lb-accordion-content\" style=\"\">\n                            <div class=\"lb-accordion-inner-wrapper\">\n\t\t\t\t\t\t\t\t<p>L\u2019amylose AL est un ensemble d\u2019affections qui surviennent lorsque l\u2019amylo\u00efde, une prot\u00e9ine anormale fabriqu\u00e9e par les plasmocytes, s\u2019accumule dans les organes du corps, tels que les reins, le tractus gastro-intestinal, le c\u0153ur ou le syst\u00e8me nerveux.<\/p>\n<ul>\n<li>Bien qu\u2019environ 10 \u00e0 15\u00a0% des personnes atteintes d\u2019un my\u00e9lome pr\u00e9sentent ou d\u00e9veloppent une amylose AL, il est rare que les personnes atteintes d\u2019amylose d\u00e9veloppent un my\u00e9lome.<\/li>\n<li>L\u2019amylose AL est g\u00e9n\u00e9ralement trait\u00e9e par chimioth\u00e9rapie, \u00e0 l\u2019aide des m\u00eames m\u00e9dicaments que ceux utilis\u00e9s pour traiter un my\u00e9lome.<\/li>\n<\/ul>\n<div class=\"lb-button-wrapper\"><a class=\"btn-with-icon \" target=\"_blank\" href=\"https:\/\/myeloma.ca\/wp-content\/uploads\/InfoSheet-FR-Amyloidosis.pdf\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" width=\"20\" height=\"20\" viewBox=\"0 0 20 20\"> <g transform=\"translate(-406 -2843)\"> <circle cx=\"10\" cy=\"10\" r=\"10\" transform=\"translate(406 2843)\" fill=\"#1c596c\"\/> <g transform=\"translate(412.135 2845)\"> <g transform=\"translate(10.732 7.866) rotate(135)\"> <path d=\"M0,4.968V0H4.968\" transform=\"translate(3.389 2.774)\" fill=\"none\" stroke=\"#fff\" stroke-linecap=\"round\" stroke-miterlimit=\"10\" stroke-width=\"1\"\/> <\/g> <\/g> <\/g> <\/svg><span>Pour en savoir plus, consultez notre InfoFeuillet Amylose amylo\u00efdes \u00e0 cha\u00eenes l\u00e9g\u00e8res (AL).<\/span><\/a><\/div>\n                            <\/div>\n                        <\/div>\n                    <\/div>\n\t\t\t\t                    <div class=\"lb-accordion-single \">\n                        <button class=\"lb-accordion-button\"\n                                type=\"button\">\n                            <span>Macroglobulin\u00e9mie de Waldenstr\u00f6m<\/span>\n                        <\/button>\n                        <div class=\"lb-accordion-content\" style=\"\">\n                            <div class=\"lb-accordion-inner-wrapper\">\n\t\t\t\t\t\t\t\t<p>La macroglobulin\u00e9mie de Waldenstr\u00f6m est une forme rare de cancer des plasmocytes caract\u00e9ris\u00e9e par une production incontr\u00f4l\u00e9e d\u2019IgM, qui provoque un \u00e9paississement du sang.<\/p>\n<ul>\n<li>Les sympt\u00f4mes peuvent comprendre une augmentation du volume des ganglions lymphatiques, de la rate ou du foie, une fatigue due \u00e0 l\u2019an\u00e9mie, des maux de t\u00eate, une perte de poids, une tendance \u00e0 saigner facilement, des probl\u00e8mes visuels, une confusion et des vertiges.<\/li>\n<li>Dans les cas extr\u00eames, une concentration \u00e9lev\u00e9e d\u2019IgM dans le sang peut provoquer une insuffisance cardiaque.<\/li>\n<\/ul>\n                            <\/div>\n                        <\/div>\n                    <\/div>\n\t\t\t\t                    <div class=\"lb-accordion-single \">\n                        <button class=\"lb-accordion-button\"\n                                type=\"button\">\n                            <span>Maladie li\u00e9e au d\u00e9p\u00f4t de cha\u00eenes l\u00e9g\u00e8res (MDCL)<\/span>\n                        <\/button>\n                        <div class=\"lb-accordion-content\" style=\"\">\n                            <div class=\"lb-accordion-inner-wrapper\">\n\t\t\t\t\t\t\t\t<p>La MDCL survient chez un tr\u00e8s faible pourcentage de personnes atteintes d\u2019un my\u00e9lome en raison de l\u2019accumulation de cha\u00eenes l\u00e9g\u00e8res anormales dans les organes, tels que les reins.<\/p>\n                            <\/div>\n                        <\/div>\n                    <\/div>\n\t\t\t\t                    <div class=\"lb-accordion-single \">\n                        <button class=\"lb-accordion-button\"\n                                type=\"button\">\n                            <span>Syndrome POEMS<\/span>\n                        <\/button>\n                        <div class=\"lb-accordion-content\" style=\"\">\n                            <div class=\"lb-accordion-inner-wrapper\">\n\t\t\t\t\t\t\t\t<p>Le syndrome POEMS est un trouble sanguin rare associ\u00e9 \u00e0 un type de my\u00e9lome peu courant appel\u00e9 my\u00e9lome ost\u00e9oscl\u00e9rotique et \u00e0 une affection connue sous le nom de maladie de Castleman.<\/p>\n<ul>\n<li>Le syndrome POEMS touche environ deux fois plus d\u2019hommes que de femmes.<\/li>\n<li>En moyenne, les hommes sont diagnostiqu\u00e9s \u00e0 50 ans, tandis que les femmes le sont plus autour de 60 ans.<\/li>\n<\/ul>\n                            <\/div>\n                        <\/div>\n                    <\/div>\n\t\t\t\t            <\/div>\n\t\t    <\/div>\n\n<\/div>\n\n<div class=\" content-2-block m-pt2 m-pb3 img-contain   block_9edb0d1b668c86f745f022509a62dd30      has-image   \" style=\"padding-left: 0rem;background-color: var(--lb--light-grey);color: #3E3A3B;\">\n    <div class=\"container\">\n        <div class=\"grid-content-2\">\n                            <div class=\"img-wrapper \">\n                    <img loading=\"lazy\" decoding=\"async\" width=\"814\" height=\"864\" src=\"https:\/\/myeloma.ca\/wp-content\/uploads\/Handbook-FR-Patient-large.png\" class=\"content-2-img\" alt=\"\" srcset=\"https:\/\/myeloma.ca\/wp-content\/uploads\/Handbook-FR-Patient-large.png 814w, https:\/\/myeloma.ca\/wp-content\/uploads\/Handbook-FR-Patient-large-283x300.png 283w, https:\/\/myeloma.ca\/wp-content\/uploads\/Handbook-FR-Patient-large-768x815.png 768w\" sizes=\"auto, (max-width: 814px) 100vw, 814px\" \/>                <\/div>\n                        <div class=\"content\">\n                <div>\n\t\t\t\t\t\t\t\t\t\t<h2>Pour plus d\u2019information, t\u00e9l\u00e9chargez le <em>Guide destin\u00e9 aux patients atteints d\u2019un my\u00e9lome multiple<\/em><\/h2>\n<p>Con\u00e7u pour offrir un soutien \u00e9ducatif aux personnes atteintes d\u2019un my\u00e9lome, \u00e0 leurs proches aidants, \u00e0 leurs familles et \u00e0 leurs amis, ce guide fournit des informations pr\u00e9cises, fiables et claires au sujet du my\u00e9lome. Il contient des discussions approfondies sur ce qu\u2019est le my\u00e9lome, ses causes et ses effets, les diff\u00e9rents traitements offerts au Canada et la fa\u00e7on de g\u00e9rer votre parcours avec un my\u00e9lome.<\/p>\n<div class=\"lb-inline-buttons\"><div class=\"lb-button-wrapper\"><a class=\"btn btn-filled \" target=\"_blank\" href=\"https:\/\/myeloma.ca\/wp-content\/uploads\/Handbook-FR-Patient.pdf\"><span>T\u00e9l\u00e9charger un exemplaire<\/span><\/a><\/div><div class=\"lb-button-wrapper\"><a class=\"btn btn-empty \" target=\"_self\" href=\"https:\/\/myeloma.ca\/fr\/formulaire-de-commande-de-materiel-pedagogique\/\"><span>Commander un exemplaire imprim\u00e9<\/span><\/a><\/div><\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n<\/div>\n    <\/div>\n<\/div>\n<\/div>\n\n            <nav class=\"master-page-anchor-wrapper\">\n            <div class=\"master-page-anchor-header\">\n                <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"24.054\" height=\"33.63\" viewBox=\"0 0 24.054 33.63\"><path d=\"M195.2,91.649h16a4.033,4.033,0,0,0,4.029-4.029V69.084a.588.588,0,0,0-.106-.348l-.047-.042-.055-.064L204.1,58.185a.594.594,0,0,0-.42-.165H195.2a4.033,4.033,0,0,0-4.029,4.029V87.62A4.033,4.033,0,0,0,195.2,91.65Zm9.088-31.518,8.715,8.316h-7.633a1.06,1.06,0,0,1-1.06-1.06ZM192.448,62.04h0a2.761,2.761,0,0,1,2.756-2.757h7.816v8.1a2.336,2.336,0,0,0,2.332,2.332h8.6v17.9a2.761,2.761,0,0,1-2.756,2.757h-16a2.761,2.761,0,0,1-2.756-2.757Z\" transform=\"translate(-191.175 -58.02)\" fill=\"#fff\"\/><\/svg>\n                <span>Sur cette page<\/span>\n                <button class=\"master-page-anchor-toggler\" type=\"button\"><i class=\"fa-solid fa-chevrons-left\"><\/i><\/button>\n            <\/div>\n            <div class=\"master-page-anchor-hiddable\">\n                <div class=\"master-page-anchor-navigation\">\n\n                <\/div>\n                <div class=\"master-page-anchor-footer\">\n                    <a href=\"#\" class=\"back-to-top\">\n                        <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" width=\"20\" height=\"20\" viewBox=\"0 0 20 20\"><g transform=\"translate(-2843 426) rotate(-90)\"><circle cx=\"10\" cy=\"10\" r=\"10\" transform=\"translate(406 2843)\" fill=\"#1c596c\"\/><g transform=\"translate(412.135 2845)\"><g transform=\"translate(10.732 7.866) rotate(135)\"><path d=\"M0,4.968V0H4.968\" transform=\"translate(3.389 2.774)\" fill=\"none\" stroke=\"#fff\" stroke-linecap=\"round\" stroke-miterlimit=\"10\" stroke-width=\"1\"\/><\/g><\/g><\/g><\/svg>\n                        <span>Retour en haut<\/span>\n                    <\/a>\n                <\/div>\n            <\/div>\n        <\/nav>\n    \n<\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":2114,"menu_order":23,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"tags":[],"class_list":["post-2016","page","type-page","status-publish","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/pages\/2016","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=2016"}],"version-history":[{"count":96,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/pages\/2016\/revisions"}],"predecessor-version":[{"id":35114,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/pages\/2016\/revisions\/35114"}],"up":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/pages\/2114"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=2016"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=2016"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}